This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Men More Likely Than Women To Commit Scientific Fraud

While calling for more research to understand the motives for scientific misconduct, Dr. Casadevall recommends periodic ethics training for scientists at all levels of academia. "Right now we target trainees for ethics training," he added. "We don't do anything after they are hired. It might help if universities required refresher courses in ethics, as they do with courses to prevent sexual harassment in the workplace. It won't stop all misconduct, but it's one place to start."

The paper is titled "Males Are Overrepresented among Life Science Researchers Committing Scientific Misconduct." Additional authors are Ferric Fang, M.D., at the University of Washington School of Medicine, Seattle, Washington, and Joan W. Bennett at Rutgers University, New Brunswick, New Jersey.

The authors report no conflict of interest.

About Albert Einstein College of Medicine of Yeshiva University

Albert Einstein College of Medicine ( http://www.einstein.yu.edu/) of Yeshiva University is one of the nation's premier centers for research, medical education and clinical investigation. During the 2012-2013 academic year, Einstein is home to 742 M.D. ( http://www.einstein.yu.edu/education/md-program/md-program.aspx?id=11144) students, 245 Ph.D. http://www.einstein.yu.edu/education/phd/) (students, 116 students in the combined M.D./Ph.D. program ( http://mstp.einstein.yu.edu/), and 360 postdoctoral research fellows ( http://www.einstein.yu.edu/research/belfer-institute/default.aspx?id=28561&ekmensel=15074e5e_4074_4116_btnlink). The College of Medicine has 2,476 full time faculty members located on the main campus and at its clinical affiliates ( http://www.einstein.yu.edu/health/affiliates.asp). In 2012, Einstein received over $160 million in awards from the NIH. This includes the funding of major research centers ( http://www.einstein.yu.edu/centers/) at Einstein in diabetes, cancer, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore Medical Center ( http://www.montefiore.org/), the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Through its extensive affiliation network involving Montefiore, Jacobi Medical Center ( http://www.nyc.gov/html/hhc/jacobi/html/home/home.shtml) –Einstein's founding hospital, and five other hospital systems in the Bronx, Manhattan, Long Island and Brooklyn,  Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States. For more information, please visit www.einstein.yu.edu and follow us on Twitter @EinsteinMed.

SOURCE Albert Einstein College of Medicine

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
3 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs